Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06238362 · ClinicalTrials.gov registry record · NA

TheraPAP Equivalence Crossover Study

A NA study of Obstructive Sleep Apnea, sponsored by SleepRes.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06238362 is a NA study of Obstructive Sleep Apnea that has completed, run by SleepRes. The registered enrollment target is 50 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06238362, a NA study of Obstructive Sleep Apnea, has completed, sponsored by SleepRes.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The present study, TheraEquivalence, is a Phase 2 crossover study designed to examine the efficacy and safety of TheraPAP (TPAP) vs. CPAP alone in the treatment of OSA.

Conditions Studied

Interventions

  • DEVICE CPAP
  • OTHER TPAP

Study Locations (1)

Tennessee

  • SleepCenters of Middle Tennessee - Clarksville

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-03-07
Est. Completion 2024-07-08
Phase NA

Sponsor

SleepRes

3 total trials

What the Registry Record Tells You About NCT06238362

The ClinicalTrials.gov registry entry for NCT06238362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (77% lower). The listed sponsor is SleepRes, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which CPAP is the first listed.

NCT06238362 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT06238362 about?

NCT06238362 is a clinical study titled "TheraPAP Equivalence Crossover Study". The present study, TheraEquivalence, is a Phase 2 crossover study designed to examine the efficacy and safety of TheraPAP (TPAP) vs. CPAP alone in the treatment of OSA.

What is the current status of trial NCT06238362?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2024-03-07. Estimated completion is 2024-07-08.

What conditions does trial NCT06238362 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT06238362?

The interventions under investigation include: CPAP (DEVICE), TPAP (OTHER).

Who is sponsoring clinical trial NCT06238362?

This trial is sponsored by SleepRes, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06238362 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.